Publications by authors named "Fenglin Fang"

Claim this Profile
M
miR-548c-3p targets TRIM22 to attenuate the Peg-IFN-α therapeutic efficacy in HBeAg-positive patients with chronic hepatitis B.
Ni Lin, Long Wang, Zhaopei Guo, Shaoying Guo, Can Liu, Fenglin Fang

Antiviral Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis